Cargando…
Peptide Signatures for Prognostic Markers of Pancreatic Cancer by MALDI Mass Spectrometry Imaging
SIMPLE SUMMARY: Pancreatic cancer remains one of the most lethal tumor entities worldwide given its overall 5-year survival after diagnosis of 9%. Thus, further understanding of molecular changes to improve individual prognostic assessment as well as diagnostic and therapeutic advancement is crucial...
Autores principales: | Loch, Florian N., Klein, Oliver, Beyer, Katharina, Klauschen, Frederick, Schineis, Christian, Lauscher, Johannes C., Margonis, Georgios A., Degro, Claudius E., Rayya, Wael, Kamphues, Carsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533220/ https://www.ncbi.nlm.nih.gov/pubmed/34681132 http://dx.doi.org/10.3390/biology10101033 |
Ejemplares similares
-
Survival rates and prognostic factors in right- and left-sided colon cancer stage I–IV: an unselected retrospective single-center trial
por: Degro, Claudius E., et al.
Publicado: (2021) -
Accuracy of various criteria for lymph node staging in ductal adenocarcinoma of the pancreatic head by computed tomography and magnetic resonance imaging
por: Loch, Florian N., et al.
Publicado: (2020) -
Rethinking the TNM Classification Regarding Direct Lymph Node Invasion in Pancreatic Ductal Adenocarcinoma
por: Speichinger, Fiona, et al.
Publicado: (2021) -
The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma
por: Loch, Florian N., et al.
Publicado: (2023) -
Diagnostic Accuracy of Magnetic Resonance Enterography for the Evaluation of Active and Fibrotic Inflammation in Crohn’s Disease
por: Loch, Florian N., et al.
Publicado: (2022)